Insights to Provider Practice of Germline Testing for Inherited Hematologic Malignancy Predisposition Syndromes to Inform Hematopoietic Stem Cell Transplantation.

Williams AS, DeSalvo A, Sanchez-Petitto G, Cooper J.

Open source

DOI
10.1016/j.jtct.2026.08.004
Published
2026-08-10
Container
Transplant Cell Ther
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtct.2026.08.004,
  title = {Insights to Provider Practice of Germline Testing for Inherited Hematologic Malignancy Predisposition Syndromes to Inform Hematopoietic Stem Cell Transplantation.},
  author = {Williams AS and  DeSalvo A and  Sanchez-Petitto G and  Cooper J.},
  year = {2026},
  journal = {Transplant Cell Ther},
  doi = {10.1016/j.jtct.2026.08.004},
  url = {https://doi.org/10.1016/j.jtct.2026.08.004}
}

RIS

TY  - JOUR
TI  - Insights to Provider Practice of Germline Testing for Inherited Hematologic Malignancy Predisposition Syndromes to Inform Hematopoietic Stem Cell Transplantation.
AU  - Williams AS
AU  -  DeSalvo A
AU  -  Sanchez-Petitto G
AU  -  Cooper J.
PY  - 2026
JO  - Transplant Cell Ther
DO  - 10.1016/j.jtct.2026.08.004
UR  - https://doi.org/10.1016/j.jtct.2026.08.004
ER  - 

APA

AS, W., A, D., G, S., & J., C. (2026). Insights to Provider Practice of Germline Testing for Inherited Hematologic Malignancy Predisposition Syndromes to Inform Hematopoietic Stem Cell Transplantation.. Transplant Cell Ther. https://doi.org/10.1016/j.jtct.2026.08.004

Source records